NCT04868396View on ClinicalTrials.gov

Patient-derived Glioma Stem Cell Organoids

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 10, 2021

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
Glioblastoma
Interventions
PROCEDURE

Tumor biopsy

Tumor material will be derived from 'left-over' tumor tissue that is not needed for standardised diagnostics (immune histochemistry and molecular testing).

Trial Locations (2)

6202AZ

Maastricht UMC+, Maastricht

6229ET

Maastricht Radiation Oncology, Maastricht

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER